MR imaging of cavernous sinus invasion by mucormycosis: a case study
Introduction
Thrombosis of the cavernous sinus is potentially a lethal condition usually due to bacterial or fungal invasion complicating sinusitis, in patients with poorly controlled diabetes or immuno-suppression [1], [2], [3], [5], [9]. Vascular, traumatic, and neoplastic etiologies of cavernous sinus thrombosis are also reported [4], [10]. Early recognition of clinical signs and symptoms of this life-threatening condition is essential [8], [11], [12].
We describe the case of a 53 year old patient with underlying SLE who suffered complications of rhino-cerebral mucormycosis while she was hospitalized. The neurologic presentation and examination suggested cavernous sinus thrombosis, which was elegantly depicted by MR imaging and confirmed by biopsy of the sinuses.
Section snippets
Case study
The patient is a 53 year old female who was in excellent health until 4 months prior to presentation. She described a progressive decline in her health characterized by fatigue, weight loss, arthralgias, and dyspnea on exertion. These symptoms were accompanied by intermittent fever, chills, nausea, and vomiting.
She presented to the emergency room where she was found to be in renal failure with a BUN of 141 and creatinine of 6.2. The signs and symptoms at presentation were thought to be due to
Discussion
Cavernous sinus thrombosis is a life-threatening illness, which, if recognized early, may result in reduced morbidity and mortality [5], [9]. As is the case in this patient, benign-appearing facial swelling may progress quickly to chemosis, proptosis and opthalmoplegia.
The venous drainage and arterial blood supply to the orbits and sinuses lends itself to bacterial and fungal pathogen spread to the cavernous sinus in a retrograde fashion via the superior and inferior ophthalmic veins [5].
Acknowledgements
Dr Al Rampy provided help with histopathology.
References (13)
- et al.
MR imaging and CT of the orbital infections and complications of acute rhinosinusitis
Radiol. Clin. North Am.
(1998) - et al.
Therapy for fungal infections
Mayo Clin Proc
(1994) - et al.
Invasive aspergillosis presenting as a cavernous sinus mass in immuno-competent individuals; report of 3 cases
Neuroradiology
(2000) - et al.
Overwhelming septic cavernous sinus thrombosis in a woman after combination of high-dose steroid and intravenous cyclophosphamide therapy for lupus nephritis
Lupus
(2000) - et al.
Orbital apex syndrome and cavernous sinus thrombosis due to infection with staphylococcus aureus and pseudomonas aeruginosa
Clin. Infect. Dis.
(1999) - et al.
Cavernous sinus invasion by pituitary adenoma
MR Imaging
(2000)
Cited by (12)
Cavernous Sinus Thrombosis related to Orbital Cellulitis Serious Complication to Prevent: a case report and literature review
2021, Annals of Medicine and SurgeryCitation Excerpt :Hematogenous propagation due to bacteremia Immunosuppression, mainly diabetes, is a classic contributor in the dissemination of infection [4]. The clinical presentation combines inflammatory proptosis, palpebral edema, and reduced ocular movement (ophthalmoplegia).
MR imaging of cavernous sinus lesions: Pictorial review
2015, Journal of NeuroradiologyCitation Excerpt :Other secondary imaging features include CS thrombosis and, stenosis, occlusion, or mycotic pseudoaneurysm of the intracavernous ICA. Infection may also extend into the subdural space with development of subdural abscesses [45,46]. Isolated involvement of the cavernous sinus by tuberculosis is very rare.
Management of ocular and orbital complications in acute sinusitis
2014, Journal Francais d'OphtalmologieSuppurative intracranial thrombophlebitis
2010, Handbook of Clinical NeurologyCitation Excerpt :In an accompanying retrospective study, mortality in patients with an accompanying intracranial hemorrhage treated with heparin was 15% as compared with 69% in similar patients not receiving anticoagulation (Einhaupl et al., 1991). Current recommendations are for use of unfractionated heparin in venous sinus thrombosis, including those cases in which hemorrhage is present (Einhaupl et al., 2006; Shafqat et al., 2006; Albers et al., 2008; Ferro and Canhao, 2008; Masuhr and Einhaupl, 2008). Treatment with low-molecular-weight heparin has also been used; however, a placebo-controlled trial, using the low-molecular-weight compound nadroparin, although yielding slightly better results in the treatment group, did not reach statistical significance (Stam et al., 2002).
Imaging of CNS Fungal Infections: Review Article
2021, Journal of the Medical Association of ThailandSeptic Cavernous Sinus Thrombosis: Case Report and Review of the Literature
2016, Neuro-Ophthalmology